Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Olodanrigan SCHEMBL8964136 | 0.90 | AGTR2 (1.00) | AGTR2AGTR1 | |
| Olodanrigan SCHEMBL421411 | 0.90 | AGTR2 (1.00) | AGTR2AGTR1 | |
| Olodanrigan SCHEMBL244657 | 0.90 | AGTR2 (1.00) | AGTR2AGTR1 | |
| Olodanrigan SCHEMBL29394365 | 0.90 | AGTR2 (1.00) | AGTR2AGTR1 | |
| SCHEMBL3516610 | 0.89 | AGTR2 (0.88) | AGTR2AGTR1 | |
| SCHEMBL10047781 | 0.88 | AGTR2 (0.64) | AGTR2AGTR1 | |
| SCHEMBL17180701 | 0.88 | AGTR2 (0.77) | AGTR2AGTR1 | |
| SCHEMBL17180727 | 0.88 | AGTR2 (0.77) | AGTR2AGTR1 | |
| SCHEMBL10073581 | 0.88 | AGTR2 (0.66) | AGTR2AGTR1 | |
| SCHEMBL3513547 | 0.86 | AGTR2 (0.83) | AGTR2AGTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120022101-A1 | SALT AND SOLVATES OF A TETRAHYDROISOQUINOLINE DERIVATIVE | SPINIFEX PHARMACEUTICALS PTY LTD, (AU) | 2012-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120022101-A1 | SALT AND SOLVATES OF A TETRAHYDROISOQUINOLINE DERIVATIVE | REN, SUDS3, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | AGTR2 75/4885AGTR1 97/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.